These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28606966)

  • 1. Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis.
    George MD; Østergaard M; Conaghan PG; Emery P; Baker DG; Baker JF
    Ann Rheum Dis; 2017 Oct; 76(10):1743-1746. PubMed ID: 28606966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state.
    Gandjbakhch F; Conaghan PG; Ejbjerg B; Haavardsholm EA; Foltz V; Brown AK; Møller Døhn U; Lassere M; Freeston J; Bøyesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; Hørslev-Petersen K; Kvien TK; McQueen F; Ostergaard M
    J Rheumatol; 2011 Sep; 38(9):2039-44. PubMed ID: 21885514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis.
    Baker JF; Conaghan PG; Emery P; Baker DG; Ostergaard M
    Ann Rheum Dis; 2017 Mar; 76(3):486-490. PubMed ID: 27432355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis.
    Lisbona MP; Solano A; Ares J; Almirall M; Salman-Monte TC; Maymó J
    J Rheumatol; 2016 Sep; 43(9):1631-6. PubMed ID: 27370881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.
    Glinatsi D; Baker JF; Hetland ML; Hørslev-Petersen K; Ejbjerg BJ; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard HM; Hansen I; Lottenburger T; Møller JM; Ørnbjerg L; Vestergaard A; Jurik AG; Thomsen HS; Torfing T; Møller-Bisgaard S; Axelsen MB; Østergaard M
    Ann Rheum Dis; 2017 Oct; 76(10):1707-1715. PubMed ID: 28611080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.
    Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Ørnbjerg LM; Glinatsi D; Møller J; Boesen M; Christensen R; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Nielsen SM; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Balding L; Jurik AG; Thomsen HS; Østergaard M
    JAMA; 2019 Feb; 321(5):461-472. PubMed ID: 30721294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.
    Gandjbakhch F; Haavardsholm EA; Conaghan PG; Ejbjerg B; Foltz V; Brown AK; Døhn UM; Lassere M; Freeston JE; Olsen IC; Bøyesen P; Bird P; Fautrel B; Hetland ML; Emery P; Bourgeois P; Hørslev-Petersen K; Kvien TK; McQueen FM; Østergaard M
    J Rheumatol; 2014 Feb; 41(2):398-406. PubMed ID: 24334647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritis.
    Peterfy C; Burmester GR; Bykerk VP; Combe BG; DiCarlo JC; Furst DE; Huizinga TW; Wong DA; Conaghan PG; Emery P
    Ann Rheum Dis; 2016 Aug; 75(8):1501-5. PubMed ID: 26865601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study.
    Burgers LE; Boeters DM; Reijnierse M; van der Helm-van Mil AHM
    Arthritis Res Ther; 2018 Apr; 20(1):68. PubMed ID: 29636084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis.
    Emery P; van der Heijde D; Ostergaard M; Conaghan PG; Genovese MC; Keystone EC; Fleischmann R; Hsia EC; Xu W; Xu S; Rahman MU
    Ann Rheum Dis; 2011 Dec; 70(12):2126-30. PubMed ID: 21926186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of rheumatoid arthritis magnetic resonance imaging inflammation thresholds associated with lack of damage progression.
    Baker JF; Østergaard M; Emery P; Baker DG; Conaghan PG
    Clin Exp Rheumatol; 2017; 35(4):607-613. PubMed ID: 28134079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active synovitis in the presence of osteitis predicts residual synovitis in patients with rheumatoid arthritis with a clinical response to treatment.
    Fukae J; Tanimura K; Isobe M; Kitano A; Henmi M; Nakai M; Aoki Y; Sakamoto F; Narita A; Ito T; Mitsuzaki A; Matsuhashi M; Shimizu M; Kamishima T; Atsumi T; Koike T
    Int J Rheum Dis; 2018 Oct; 21(10):1809-1814. PubMed ID: 28160411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of initiating biologics compared to intensifying conventional DMARDs on clinical and MRI outcomes in established rheumatoid arthritis patients in clinical remission: Secondary analyses of the IMAGINE-RA trial.
    Møller-Bisgaard S; Hørslev-Petersen K; Ejbjerg B; Hetland ML; Christensen R; Ørnbjerg LM; Glinatsi D; Møller JM; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Bennett P; Hendricks O; Asmussen K; Kowalski M; Lindegaard H; Bliddal H; Krogh NS; Ellingsen T; Nielsen AH; Larsen L; Jurik AG; Thomsen HS; Østergaard M
    Scand J Rheumatol; 2022 Jul; 51(4):268-278. PubMed ID: 34474649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent low grade synovitis without erosive progression in magnetic resonance imaging of rheumatoid arthritis patients treated with infliximab over 1 year.
    Fonseca JE; Canhão H; Tavares NJ; Cruz M; Branco J; Queiroz MV
    Clin Rheumatol; 2009 Oct; 28(10):1213-6. PubMed ID: 19504146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial.
    Møller-Bisgaard S; Hørslev-Petersen K; Ørnbjerg LM; Ejbjerg B; Hetland ML; Møller JM; Nielsen SM; Glinatsi D; Boesen M; Stengaard-Pedersen K; Madsen OR; Jensen B; Villadsen JA; Hauge EM; Hendricks O; Lindegaard H; Krogh NS; Jurik AG; Thomsen H; Christensen R; Østergaard M
    RMD Open; 2024 Mar; 10(1):. PubMed ID: 38490697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of magnetic resonance imaging in detecting subclinical synovitis in rheumatoid arthritis and correlation of imaging findings with interleukin-18 levels.
    Chew LC; Chandra Mohan P; Chan LP; Fong KY; Thumboo J
    Int J Rheum Dis; 2016 Aug; 19(8):790-8. PubMed ID: 25123522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACPA-negative and ACPA-positive RA patients achieving disease resolution demonstrate distinct patterns of MRI-detected joint-inflammation.
    Verstappen M; Matthijssen XME; Connolly SE; Maldonado MA; Huizinga TWJ; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2022 Dec; 62(1):124-134. PubMed ID: 35583256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of Synovial Tissue-Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment-Naive Rheumatoid Arthritis Patients.
    Alivernini S; Tolusso B; Gessi M; Gigante MR; Mannocci A; Petricca L; Perniola S; Di Mario C; Bui L; Fedele AL; Capacci A; Bruno D; Peluso G; La Torre G; Federico F; Ferraccioli G; Gremese E
    Arthritis Rheumatol; 2021 Sep; 73(9):1601-1613. PubMed ID: 33750008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictors.
    Terslev L; Ostergaard M; Georgiadis S; Brahe CH; Ellegaard K; Dohn UM; Fana V; Møller T; Juul L; Huynh TK; Krabbe S; Ornbjerg LM; Glinatsi D; Røgind H; Hansen A; Nørregaard J; Jacobsen S; Jensen DV; Manilo N; Asmussen K; Boesen M; Rastiemadabadi Z; Morsel-Carlsen L; Møller JM; Krogh NS; Hetland ML
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36549857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.